HK1206389A1 - Methods for improving resistance to skeletal muscle fatigue - Google Patents

Methods for improving resistance to skeletal muscle fatigue

Info

Publication number
HK1206389A1
HK1206389A1 HK15106995.5A HK15106995A HK1206389A1 HK 1206389 A1 HK1206389 A1 HK 1206389A1 HK 15106995 A HK15106995 A HK 15106995A HK 1206389 A1 HK1206389 A1 HK 1206389A1
Authority
HK
Hong Kong
Prior art keywords
methods
skeletal muscle
muscle fatigue
improving resistance
improving
Prior art date
Application number
HK15106995.5A
Other languages
English (en)
Chinese (zh)
Inventor
Fady Malik
R Jasper Jeffrey
Adam Kennedy
Darren Hwee
Original Assignee
Cytokinetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytokinetics Inc filed Critical Cytokinetics Inc
Publication of HK1206389A1 publication Critical patent/HK1206389A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK15106995.5A 2012-04-11 2015-07-22 Methods for improving resistance to skeletal muscle fatigue HK1206389A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261623003P 2012-04-11 2012-04-11
US201261646842P 2012-05-14 2012-05-14
US201261693061P 2012-08-24 2012-08-24
US201261735809P 2012-12-11 2012-12-11
PCT/US2013/036114 WO2013155262A2 (en) 2012-04-11 2013-04-11 Methods for improving resistance to skeletal muscle fatigue

Publications (1)

Publication Number Publication Date
HK1206389A1 true HK1206389A1 (en) 2016-01-08

Family

ID=49328282

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15106995.5A HK1206389A1 (en) 2012-04-11 2015-07-22 Methods for improving resistance to skeletal muscle fatigue

Country Status (15)

Country Link
US (2) US20150250784A1 (ja)
EP (1) EP2836590A4 (ja)
JP (2) JP6352244B2 (ja)
KR (1) KR102163931B1 (ja)
CN (2) CN104395458A (ja)
AU (3) AU2013245917A1 (ja)
BR (1) BR112014025251B1 (ja)
CA (1) CA2869675C (ja)
EA (1) EA032480B1 (ja)
HK (1) HK1206389A1 (ja)
IL (2) IL234886A (ja)
MX (1) MX2014012179A (ja)
PH (1) PH12014502286A1 (ja)
SG (2) SG10201704166RA (ja)
WO (1) WO2013155262A2 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8299248B2 (en) 2006-08-02 2012-10-30 Cytokinetics, Incorporated Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
WO2011133920A1 (en) 2010-04-23 2011-10-27 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
KR101951220B1 (ko) 2011-07-13 2019-02-22 싸이토키네틱스, 인코포레이티드 조합 als 치료법
EP2970240B1 (en) 2013-03-14 2018-01-10 Novartis AG 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
HRP20220183T1 (hr) * 2014-04-29 2022-04-29 Cytokinetics, Inc. Postupci smanjivanja propadanja vitalnog kapaciteta
CA2959208C (en) 2014-08-29 2023-09-19 Tes Pharma S.R.L. Pyrimidine derivatives and their use as inhibitors of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase
AU2015313221B2 (en) * 2014-09-09 2019-11-21 Cytokinetics Incorporated Novel pharmaceutical composition for prevention and/or treatment of urinary incontinence
NZ746311A (en) 2016-02-12 2022-08-26 Cytokinetics Inc Tetrahydroisoquinoline derivatives
AU2017296338A1 (en) 2016-07-14 2019-01-03 Pfizer Inc. Novel pyrimidine carboxamides as inhibitors of vanin-1 enzyme
WO2018165520A1 (en) 2017-03-10 2018-09-13 Vps-3, Inc. Metalloenzyme inhibitor compounds
EP4240724A1 (en) 2020-11-06 2023-09-13 Cytokinetics, Inc. Bicyclic 1,4-diazepanones and therapeutic uses thereof
US12084453B2 (en) 2021-12-10 2024-09-10 Incyte Corporation Bicyclic amines as CDK12 inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005139081A (ja) * 2003-11-04 2005-06-02 Takada Seiyaku Kk ビントペロール含有製剤
US8227603B2 (en) * 2006-08-01 2012-07-24 Cytokinetics, Inc. Modulating skeletal muscle
US8299248B2 (en) * 2006-08-02 2012-10-30 Cytokinetics, Incorporated Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
SI2583970T1 (sl) * 2006-08-02 2016-03-31 Cytokinetics, Inc. Določene kemijske enote, sestavki in postopki, ki obsegajo imidazopirimidine
CN101983061A (zh) * 2008-02-04 2011-03-02 赛特凯恩蒂克公司 某种化学物质、组合物和方法
AR081331A1 (es) * 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
EA031183B1 (ru) * 2012-04-02 2018-11-30 Сайтокинетикс, Инк. Способы улучшения функции диафрагмы

Also Published As

Publication number Publication date
US20150250784A1 (en) 2015-09-10
EA032480B1 (ru) 2019-06-28
MX2014012179A (es) 2015-07-14
AU2013245917A1 (en) 2014-10-23
PH12014502286B1 (en) 2014-12-15
KR20160046694A (ko) 2016-04-29
KR102163931B1 (ko) 2020-10-12
US20190167676A1 (en) 2019-06-06
IL250473A0 (en) 2017-03-30
JP6535727B2 (ja) 2019-06-26
EP2836590A2 (en) 2015-02-18
CA2869675A1 (en) 2013-10-17
SG11201406359TA (en) 2014-11-27
WO2013155262A2 (en) 2013-10-17
JP2015516392A (ja) 2015-06-11
EA201491666A1 (ru) 2015-03-31
CA2869675C (en) 2022-06-14
CN104395458A (zh) 2015-03-04
EP2836590A4 (en) 2016-04-13
PH12014502286A1 (en) 2014-12-15
CN111840294A (zh) 2020-10-30
JP2018048209A (ja) 2018-03-29
SG10201704166RA (en) 2017-06-29
WO2013155262A3 (en) 2013-12-27
AU2018200930A1 (en) 2018-03-01
AU2019268177A1 (en) 2019-12-12
BR112014025251B1 (pt) 2021-03-02
IL234886A (en) 2017-02-28
JP6352244B2 (ja) 2018-07-04

Similar Documents

Publication Publication Date Title
HK1206389A1 (en) Methods for improving resistance to skeletal muscle fatigue
IL226745A0 (en) Simulates a physical heart
SG11201404215UA (en) Exercise assisting tool
HK1205031A1 (en) Exercise mat
EP2742938A4 (en) AMINO-ACIDIC COMPOSITION FOR IMPROVED RECOVERY OF MUSCULAR TEMPERING
EP2788772A4 (en) METHOD FOR DETERMINING THE TOTAL BODY TWEEk MUSCLE MASS
SI2729134T1 (sl) Sestavki in postopki za premagovanje odpornosti proti tramadolu
SG11201501802VA (en) Implement for training facial muscle
EP2844357A4 (en) Exercise / TRAINING MACHINE
HUE043603T2 (hu) Sejtmentesített izommátrix
EP2875730A4 (en) METHOD FOR THE RESISTANT FORMATION OF PLANTS AGAINST STRESS
GB201212069D0 (en) Predicting resistance to disease
EP2894215A4 (en) FAT COMPOSITION
EP2904119A4 (en) PROCEDURE FOR SIDS ASSOCIATED WITH THE DNA COLLECTION PATIENT
PL2831589T3 (pl) Mutanty C-RAF, które nadają oporność na inhibitory RAF
EP2854851A4 (en) METHODS ASSOCIATED WITH TRASTUZUMAB
EP2856158A4 (en) PROCEDURE RELATED TO RITUXIMAB
AP2015008378A0 (en) Improvements relating to buoyancy-supported risers
GB201509702D0 (en) Exercise effect analysis system
GB201211746D0 (en) Improvements in or relating to exercise devices
GB201119736D0 (en) Muscle stimulation
ZA201406595B (en) Sports grips
GB2507789B (en) Hand-tool grips
GB2509190B (en) Padded stick as an exercise aid
GB201220690D0 (en) Improvements relating to pasteurisation